Ther Adv Musculoskelet Dis. 2017 Apr;9(4):89-95. doi: 10.1177/1759720X17692502. Epub 2017 Feb 14.
The role of vitamin D in maintaining bone health in older people.
Therapeutic advances in musculoskeletal disease
Thomas R Hill, Terry J Aspray
Affiliations
Affiliations
- Human Nutrition Research Centre, Newcastle University, Newcastle upon Tyne, UK.
- Consultant Physician, Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK, Institute for Cellular Medicine, Newcastle University, Newcastle upon Tyne.
PMID: 28382112
PMCID: PMC5367643 DOI: 10.1177/1759720X17692502
Abstract
This review summarises aspects of vitamin D metabolism, the consequences of vitamin D deficiency, and the impact of vitamin D supplementation on musculoskeletal health in older age. With age, changes in vitamin D exposure, cutaneous vitamin D synthesis and behavioural factors (including physical activity, diet and sun exposure) are compounded by changes in calcium and vitamin D pathophysiology with altered calcium absorption, decreased 25-OH vitamin D [25(OH)D] hydroxylation, lower renal fractional calcium reabsorption and a rise in parathyroid hormone. Hypovitaminosis D is common and associated with a risk of osteomalacia, particularly in older adults, where rates of vitamin D deficiency range from 10-66%, depending on the threshold of circulating 25(OH)D used, population studied and season. The relationship between vitamin D status and osteoporosis is less clear. While circulating 25(OH)D has a linear relationship with bone mineral density (BMD) in some epidemiological studies, this is not consistent across all racial groups. The results of randomized controlled trials of vitamin D supplementation on BMD are also inconsistent, and some studies may be less relevant to the older population, as, for example, half of participants in the most robust meta-analysis were aged under 60 years. The impact on BMD of treating vitamin D deficiency (and osteomalacia) is also rarely considered in such intervention studies. When considering osteoporosis, fracture risk is our main concern, but vitamin D therapy has no consistent fracture-prevention effect, except in studies where calcium is coprescribed (particularly in frail populations living in care homes). As a J-shaped effect on falls and fracture risk is becoming evident with vitamin D interventions, we should target those at greatest risk who may benefit from vitamin D supplementation to decrease falls and fractures, although the optimum dose is still unclear.
Keywords: Vitamin D; bone health; older people; osteomalacia; osteoporosis
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
References
- Lancet. 2014 Apr 12;383(9925):1292 - PubMed
- J Bone Miner Res. 2013 Oct;28(10):2202-13 - PubMed
- Am J Med. 2004 May 1;116(9):634-9 - PubMed
- J Clin Densitom. 2006 Jan-Mar;9(1):120-7 - PubMed
- Bone. 1986;7(6):421-5 - PubMed
- J Clin Invest. 1973 Nov;52(11):2672-81 - PubMed
- Age Ageing. 2013 Mar;42(2):186-90 - PubMed
- J Bone Miner Res. 2016 Nov;31(11):2024-2031 - PubMed
- Arch Osteoporos. 2012;7:155-72 - PubMed
- J Clin Endocrinol Metab. 2013 Dec;98(12):E1927-35 - PubMed
- South Med J. 2001 Jun;94(6):569-73 - PubMed
- BMJ. 2010 Jan 12;340:b5463 - PubMed
- J Bone Miner Res. 1991 Feb;6(2):125-32 - PubMed
- Rheumatology (Oxford). 2007 Dec;46(12):1852-7 - PubMed
- Calcif Tissue Int. 2013 Feb;92(2):118-27 - PubMed
- J Bone Miner Res. 2010 Feb;25(2):305-12 - PubMed
- Age Ageing. 1984 Jan;13(1):14-20 - PubMed
- Maturitas. 2015 Feb;80(2):126-32 - PubMed
- Lancet. 1989 Nov 4;2(8671):1104-5 - PubMed
- BMJ. 2009 Oct 01;339:b3692 - PubMed
- JAMA Intern Med. 2016 Feb;176(2):175-83 - PubMed
- Age Ageing. 1980 Nov;9(4):249-52 - PubMed
- Lancet. 1970 Sep 12;2(7672):535-7 - PubMed
- J Clin Endocrinol Metab. 2012 Oct;97(10):3550-6 - PubMed
- Arch Gerontol Geriatr. 2014 Jul-Aug;59(1):78-82 - PubMed
- Am J Clin Nutr. 2009 May;89(5):1366-74 - PubMed
- Eur J Clin Nutr. 2005 Apr;59(4):533-41 - PubMed
- Osteoporos Int. 2013 May;24(5):1769-70 - PubMed
- Lancet. 2014 Jan 11;383(9912):146-55 - PubMed
- Endocrinology. 2014 Sep;155(9):3210-3 - PubMed
- Osteoporos Int. 2016 Mar;27(3):1199-208 - PubMed
- JAMA. 2005 May 11;293(18):2257-64 - PubMed
- Am J Clin Nutr. 1994 Oct;60(4):619-30 - PubMed
- Age Ageing. 2006 Sep;35(5):482-6 - PubMed
- J Clin Endocrinol Metab. 2003 Jan;88(1):185-91 - PubMed
- JAMA. 2010 May 12;303(18):1815-22 - PubMed
- J Clin Endocrinol Metab. 2011 Oct;96(10):3250-6 - PubMed
- Cochrane Database Syst Rev. 2014 Apr 14;(4):CD000227 - PubMed
- J Clin Endocrinol Metab. 1992 Oct;75(4):1099-103 - PubMed
- J Clin Invest. 1985 Oct;76(4):1536-8 - PubMed
- J Bone Miner Res. 1993 Jul;8(7):779-87 - PubMed
- J Clin Endocrinol Metab. 2006 Aug;91(8):2980-5 - PubMed
- Osteoporos Int. 2011 Mar;22(3):859-71 - PubMed
- Br J Nutr. 2011 Jan;105(1):144-56 - PubMed
- J Sci Med Sport. 2015 Sep;18(5):575-80 - PubMed
- J Bone Miner Res. 1989 Aug;4(4):469-75 - PubMed
- Lancet. 1995 Jul 22;346(8969):207-10 - PubMed
- BMJ. 2003 Mar 1;326(7387):469 - PubMed
- N Engl J Med. 2012 Jul 5;367(1):40-9 - PubMed
- J Intern Med. 2006 Sep;260(3):245-54 - PubMed
Publication Types
Grant support